Genomed Spólka Akcyjna (WSE:GEN)
Poland · Delayed Price · Currency is PLN 30.00
0.00 (0.00%)
At close: Aug 13, 2026
Genomed Spólka Akcyjna Ratios and Metrics
Market cap in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 39 | 32 | 35 | 39 | 45 | 45 | |
Market Cap Growth | 15.62% | -9.02% | -10.74% | -12.35% | -0.58% | 3.64% |
Enterprise Value | 34 | 26 | 32 | 36 | 42 | 42 |
Last Close Price | 29.60 | 22.95 | 25.22 | 28.26 | 32.24 | 32.43 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.73 | 9.41 | 31.80 | 42.51 | 132.93 | 36.50 |
PS Ratio | 1.32 | 1.10 | 1.53 | 1.75 | 2.20 | 2.27 |
PB Ratio | 2.78 | 2.27 | 3.28 | 3.91 | 4.92 | 5.14 |
P/TBV Ratio | 2.79 | 2.27 | 3.30 | 3.95 | 4.92 | 5.14 |
P/FCF Ratio | 21.05 | 15.17 | - | 22.33 | - | 26.65 |
P/OCF Ratio | 11.91 | 9.89 | 21.44 | 20.02 | - | 20.43 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.14 | 0.91 | 1.39 | 1.61 | 2.03 | 2.11 |
EV/EBITDA Ratio | 7.21 | 5.48 | 16.38 | 19.46 | 38.57 | 19.97 |
EV/EBIT Ratio | 8.70 | 6.47 | 26.51 | 29.13 | 116.70 | 31.41 |
EV/FCF Ratio | 18.07 | 12.52 | - | 20.55 | - | 24.78 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Debt / Equity Ratio | -0.39 | -0.43 | -0.49 | -0.52 | -0.38 | -0.55 |
Net Debt / EBITDA Ratio | -1.19 | -1.27 | -2.69 | -2.82 | -3.23 | -2.31 |
Net Debt / FCF Ratio | -2.97 | -2.89 | 194.28 | -2.98 | 5.79 | -2.87 |
Asset Turnover | 2.09 | 2.01 | 1.88 | 2.00 | 1.98 | 1.96 |
Inventory Turnover | 5.92 | 4.69 | 4.10 | 4.10 | 5.01 | 5.74 |
Quick Ratio | 6.89 | 4.52 | 4.52 | 3.76 | 4.32 | 4.24 |
Current Ratio | 8.18 | 5.48 | 5.89 | 4.78 | 6.05 | 5.12 |
Return on Equity (ROE) | 24.55% | 27.38% | 10.64% | 9.65% | 3.77% | 15.14% |
Return on Assets (ROA) | 17.04% | 17.63% | 6.14% | 6.91% | 2.15% | 8.22% |
Return on Invested Capital (ROIC) | 37.33% | 50.45% | 21.35% | 20.98% | 6.82% | 31.58% |
Return on Capital Employed (ROCE) | 26.70% | 28.30% | 11.10% | 12.30% | 3.90% | 15.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.85% | 10.63% | 3.15% | 2.35% | 0.75% | 2.74% |
FCF Yield | 4.75% | 6.59% | -0.08% | 4.48% | -1.34% | 3.75% |
Dividend Yield | 5.07% | 6.54% | - | - | - | - |
Total Shareholder Return | 5.00% | 6.54% | - | - | - | - |